A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase
Clinical trial NCT04126681 · COMPLETED
Trial details
- NCT number
- NCT04126681
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-21
- Primary completion
- 2024-08-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.